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INVESTIGATION
Identiﬁcation of eQTLs for Hepatic Xbp1s and
Socs3 Gene Expression in Mice Fed a High-Fat,
High-Caloric Diet
Sarina Pasricha,*,† Jane Kenney-Hunt,‡ Kristy Anderson,* Nadereh Jafari,§ Rabea A. Hall,**
Frank Lammert,** James Cheverud,†† and Richard M. Green*,1
*Department of Internal Medicine, Northwestern University, Chicago, Illinois, †Department of Internal Medicine,
University of North Carolina, Chapel Hill, North Carolina, ‡Department of Biology and Environmental Science,
Westminster College, Fulton, Missouri, §Center for Genetic Medicine, Northwestern University, Chicago, Illinois,
**Department of Medicine II, Saarland University Medical Center, Homburg, Germany, and ††Department of Biology,
Loyola University, Chicago, Illinois
ABSTRACT Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent form of human hepatic disease
and feeding mice a high-fat, high-caloric (HFHC) diet is a standard model of NAFLD. To better understand
the genetic basis of NAFLD, we conducted an expression quantitative trait locus (eQTL) analysis of mice fed
a HFHC diet. Two-hundred sixty-ﬁve (A/J · C57BL/6J) F2 male mice were fed a HFHC diet for 8 wk. eQTL
analysis was utilized to identify genomic regions that regulate hepatic gene expression of Xbp1s and Socs3.
We identiﬁed two overlapping loci for Xbp1s and Socs3 on Chr 1 (164.0–185.4 Mb and 174.4–190.5 Mb,
respectively) and Chr 11 (41.1–73.1 Mb and 44.0–68.6 Mb, respectively), and an additional locus for Socs3
on Chr 12 (109.9–117.4 Mb). C57BL/6J-Chr 11A/J/ NaJ mice fed a HFHC diet manifested the A/J phenotype
of increased Xbp1s and Socs3 gene expression (P , 0.05), whereas C57BL/6J-Chr 1A/J/ NaJ mice retained
the C57BL/6J phenotype. In addition, we replicated the eQTLs on Chr 1 and Chr 12 (LOD scores $3.5)
using mice from the BXD murine reference panel challenged with CCl4 to induce chronic liver injury and
ﬁbrosis. We have identiﬁed overlapping eQTLs for Xbp1 and Socs3 on Chr 1 and Chr 11, and consomic
mice conﬁrmed that replacing the C57BL/6J Chr 11 with the A/J Chr 11 resulted in an A/J phenotype for
Xbp1 and Socs3 gene expression. Identiﬁcation of the genes for these eQTLs will lead to a better un-
derstanding of the genetic factors responsible for NAFLD and potentially other hepatic diseases.
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Nonalcoholic fatty liver disease (NAFLD) is the most common cause
of abnormal liver function tests and is one of the most frequent causes
of chronic liver disease in the United States. NAFLD has a prevalence
as high as 30% in the general population and 75% in obese patients
(Lazo and Clark 2008; Reid 2001; Wanless and Lentz 1990; Browning
and Horton 2004). NAFLD represents a spectrum of diseases, including
simple steatosis, nonalcoholic steatohepatitis (NASH) with or without
ﬁbrosis, cirrhosis, and end-stage liver disease. NAFLD has been closely
linked to the metabolic syndrome characterized by obesity, dyslipidemia,
and insulin resistance (Ron and Walter 2007; Vanni et al. 2010;
Speliotes et al. 2008; Speliotes et al. 2010). Liver-related and overall
mortality rates are signiﬁcantly higher in patients with NAFLD compared
with the general population (Ong et al. 2008). In fact, it is estimated that
NAFLD/cryptogenic cirrhosis will be the leading indication for liver
transplantation within a decade. Despite the high prevalence of NAFLD,
the pathogenesis and genetic mechanisms responsible for the susceptibil-
ity and progression of NAFLD remain poorly understood.
Several studies support the important role of genetics in the
pathogenesis of nonalcoholic steatohepatitis (Willner et al. 2001; Angulo
2002; Silverman et al. 1989; Wagenknecht et al. 2009). NASH is a poly-
genic disease in which susceptible individuals can develop disease
when exposed to environmental factors such as excess calorie intake,
obesity, and insulin resistance (Speliotes et al. 2008; Willner et al.
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2001; Angulo 2002). The unfolded protein response (UPR) is a pro-
tective cellular signaling response that is activated in response to
endoplasmic reticulum (ER) stress, and the hepatic UPR is activated
by insulin resistance, obesity, and fatty liver (Cnop et al. 2012; Eizirik
et al. 2008; Ji and Kaplowitz 2006; Brenner et al. 2013). In fact, X-box
binding protein-1 spliced (Xbp1s) is a key regulator of the UPR and
dysregulation of hepatic Xbp1s has been shown to be important in the
pathogenesis of human nonalcoholic fatty liver diseases (Puri et al.
2008). Xbp1s is the spliced form of Xbp1 that occurs when the Xbp1
transcript is spliced by Inositol Requiring Kinase 1-a (IRE1a) in re-
sponse to ER stress. When this occurs, Xbp1s regulates the expression
of its down-stream target genes (Ron and Walter 2007; Puri et al.
2008; Kaser et al. 2008; Tilg and Moschen 2010; Lee et al. 2008).
Suppressor of Cytokine Signaling 3 (SOCS3) is an inﬂammatory
mediator that has also been previously identiﬁed to be important in
glucose and lipid metabolism, and it has been implicated in the path-
ogenesis of experimental models of NAFLD (Wang et al. 2009; Ihle
1995; Handy et al. 2011; Brenner et al. 2013; Moschen et al. 2010;
Clementi et al. 2009; Ogawa and Kasuga 2008; Ueki et al. 2005; Tilg
2010). In fact, when mice with a liver-speciﬁc deletion of Socs3 are fed
a high-fat diet, they develop increased liver fat and inﬂammation com-
pared with control mice (Sachithanandan et al. 2010). Therefore, both
human and murine studies demonstrate that hepatic XBP1s and SOCS3
expression are important in the pathogenesis of fatty liver diseases.
Quantitative trait loci (QTL) analysis is a well-established genetic
technique for mapping the chromosomal loci of complex traits in
rodents, humans, multiple animals, and plants (Rapp 2000; Paterson
et al. 1991; Fullerton et al. 2003). QTL analysis using experimental
crosses of mice has been successfully applied to identify QTL in sev-
eral polygenic diseases of the metabolic syndrome, including obesity,
diabetes, and hypertension (Mu et al. 1999; Pomp 1997; Wang et al.
2012). The aim of this investigation is to utilize the high-fat, high-
caloric (HFHC) dietary model of murine fatty liver disease and eQTL
analysis in an F2 intercross of C57BL/6J and A/J mice to identify
eQTLs and candidate genes that are important in the pathogenesis
and progression of NAFLD. In addition, we tested allele effects of
candidate regions in consomic strains (C57BL/6J-Chr 1A/J/ NaJ and
C57BL/6J-Chr 11A/J/ NaJ) where the chromosome carrying the eQTL
region has been substituted from the A/J background into a C57BL/6J
background.
To help determine the relevance of the identiﬁed loci in other
forms of liver injury, we used the CCl4 hepatotoxicity model and the
BXD murine reference panel for systems genetics (Andreux et al.
2012). BXD mice are recombinant inbred lines generated from F1
hybrids of C57BL/6J and DBA/2J mice by consecutive brother–sister
matings of the F2 progeny for more than 20 generations. These ge-
netically mosaic lines are homozygous at every genetic locus and
represent a panel that has been extensively genotyped across the
genomes.
Identifying candidate NAFLD genes will be essential for enhancing
our understanding of the genetic factors that are important in the
pathogenesis and progression of NAFLD and in subsequently
developing rational therapeutic strategies for this common liver
disease.
MATERIALS AND METHODS
Animals
A/J, C57BL/6J, B6AF1/J, C57BL/6J-Chr 1A/J/ NaJ, and C57BL/6J-Chr
11A/J/ NaJ male mice were purchased from Jackson Laboratory (Bar
Harbor, ME). A/J and C57BL/6J mice were chosen following a pre-
liminary screen of six mouse strains (A/J, C57BL/6J, DBA-2J, AKR/J,
129x1/SvJ) for hepatic expression of Xbp1s and Socs3. The A/J and
C57BL/6J recombinant inbred (RI) strains of mice had no signiﬁcant
differences in baseline hepatic Xbp1s and Socs3 expression when fed
chow, yet elicited different susceptibilities of hepatic Xbp1s and Socs3
gene expression when fed the high-fat diet. C57BL/6J-Chr 1A/J/ NaJ
mice are chromosome substitution strains (CSS) of consomic mice
where chromosome 1 from strain A/J has been substituted on a C57BL/
6J background; C57BL/6J-Chr 11A/J/ NaJ mice are CSS mice where
chromosome 11 from strain A/J has been substituted into a C57BL/
6J background. Chromosomes 1 and 11 substitute lines were selected
because eQTLs for both Xbp1s and Socs3 localized to these chromo-
somes. B6AF1/J mice are an F1 hybrid of C57BL/6J female and A/J
male mice, and these mice were crossed to generate 265 F2 genera-
tion mice from 74 litters that were used for eQTL analysis. Male 8-
to 10-wk-old mice were used for all experiments because differences
in hepatic Xbp1s and Socs3 expression were slightly greater in male
compared with female mice. We also analyzed 30 BXD recombinant
inbred lines with an average of six mice per sex and line. Mice were
purchased (BXD lines 1, 2, 6, 11, 12, 13, 14, 19, 24a, 27, 28, 31, 32,
33, 34, 39, 40, 42, 96, and 98) from Jackson Laboratory and (BXD
lines 43, 51, 55, 62, 65, 69, 73, 75, 87, and 90) from Oak Ridge
Laboratory. All animal protocols were approved by the Northwest-
ern University Institutional Animal Care and Use Committee
(IACUC) or according to all relevant welfare regulations of the
Animal Care and Use Committee for Saarland University that
approved the protocols (TV 10/2008).
Phenotypic analysis of mice
In HFHC diet feeding studies, A/J, C57BL/6J, C57BL/6J-Chr 1A/J/ NaJ,
or C57BL/6J-Chr 11A/J/ NaJ mice were given free access to water and
a HFHC diet (60% fat, 20% protein, 20% carbohydrates; D12492;
Research Diets, New Brunswick, NJ) for 8 wk. Body weight was
recorded after 0, 4, and 8 wk of dietary feeding. After 8 wk, the mice
were killed using CO2 narcosis after a 4-hr fast, and blood was col-
lected by cardiac puncture. The liver and spleen were rapidly excised,
rinsed in ice-cold saline, weighed, and snap-frozen in liquid nitrogen.
Tails were clipped and snap-frozen in liquid nitrogen and stored at
280 until analyzed. To assess for liver injury and components of the
metabolic syndrome, hepatic triglyceride levels were measured enzy-
matically on liver homogenate according to the manufacturer (Pointe
Scientiﬁc, Canton MI); serum alanine aminotransferase (ALT) was
measured using a spectrophotometric assay kit (Biotron, Hemet,
CA). Serum glucose was measured by the glucose oxidase method
using a colorimetric meter (Glucose Assay Kit). Serum insulin levels
were determined using the Meso Scale Discovery system (Gaithers-
burg, MD). Quantitative insulin sensitivity check index (QUICKI) was
calculated using 4-hr fasting insulin and glucose levels. In RT-PCR
experiments, total RNA isolation and reverse-transcription were per-
formed from liver using Trizol (Invitrogen) and qScript One-Step
CYBR Green qRT-PCR (Quanta Biosciences). Xbp1s forward primers
were sense 59-AAGAACACGCTTGGGAATGG-39 and Xbp1s reverse
primers were anti-sense 59-CTGCACCTGCTGCGGAC-39. Socs3 for-
ward primers were sense 59-CCCTTGCAGTTCTAAGTTCAACA-39
and Socs3 reverse primers were anti-sense 59-ACCTTTGACAAGCG
GACTCTC-39. Gapdh was used as an internal control and was un-
changed under the experimental condition. Studies were performed in
A/J, C57BL/6J, C57BL/6J-Chr 1A/J/ NaJ, or C57BL/6J-Chr 11A/J/ NaJ
and F2 (A/J · C57BL/6J) mice. Comparisons were performed using
488 | S. Pasricha et al.
Student’s t-test or ANOVA, and the Tukey range test was performed
as a post-hoc test.
eQTL analysis of mice fed a high-fat, high-caloric diet
DNA was extracted from mouse tails and medium density linkage
panel genotyping was performed at the Center of Genomic Studies
at Northwestern University using Illumina Medium Density Micro-
array Chips (Illumina, San Diego, CA); 959 polymorphic SNPs were
identiﬁed between C57BL/6J and the A/J parental strains, and
genotyping and phenotyping for hepatic gene expression were
performed on 265 F2 male mice. eQTL analysis was performed
using R/qtl (Broman et al. 2003). Genome-wide 5% signiﬁcance
thresholds were generated in R/qtl using the scanone function and
1000 permutations. The LOD threshold for autosomes is 3.91 and
is 2.87 for the X chromosome. Additional chromosome-wide 5%
signiﬁcance thresholds were generated using the method of Li and
Ji (2005) (Chen and Storey 2006). The phenotypes of Xbp1s, Socs3,
glucose, and insulin were log-transformed before analysis. SNP
genomic positions obtained from Ensembl.org, build GRCm38.
p3. Genes, predicted genes, and differential SNPs and nsSNPs were
obtained from Mouse Genome Informatics Database (MGI 5.20).
eQTL regions are deﬁned as the 1.0 LOD-drop of both sides of the
peak of the eQTL. The SNP marker closest to the 1.0 LOD-drop
was utilized as the physical boundary of the interval. Xbp1 is lo-
cated at Chr11: 5,520,659–5,525,893; murine Socs3 is at Chr11:
117,966,079–117,970,047 bp.
Microarray analysis of mice fed a high-fat,
high-caloric diet
For microarray studies analyzing the differentially expressed hepatic
genes between A/J and C57BL/6J mice, analysis was performed using
a minimum of three samples of hepatic mRNA, with each sample
pooled from two mice (San Diego, CA). We utilized Illumina Mouse
Ref 8 chips containing 25,697 probes of 18,708 genes. All samples met
the Illumina standard quality control checks. Data quality checks were
performed using the Bioconductor Lumi package for R statistical
programming environment. The intensity distribution of the samples
was examined by histogram and box plots. The data processing also
includes a normalization procedure utilizing a quantile normalization
method (Bolstad et al. 2003) to reduce the obscuring variation be-
tween microarrays, which might be introduced during the processes of
sample preparation, manufacture, ﬂuorescence labeling, hybridization,
and/or scanning. Hierarchical clustering and principal component
analysis were performed on the normalized signal data to assess the
sample relationship and variability.
Using the criteria that a probe is considered not to be expressed if
no probes’ background P value was less than 0.01, 13,060 out of
25,697 probes were kept for further differential gene expression
analyses. A modiﬁed t-test using limma’s algorithm of ﬁtting to
linear models was used to obtain an adjusted P value, using the
Benjamini-Hochberg method to estimate the false discovery rate.
For each requested comparison, genes that showed a fold-change
in expression of at least 1.5 and an adjusted P value of 0.05 or less
were considered differentially expressed. The probes’ genes were
identiﬁed using the lumiMouse DB package (Bolstad et al. 2003).
eQTL analysis of BXD mice treated with carbon
tetrachloride (CCl4)
Mice from C57BL/6J, DBA/2J, B6D2 F1 hybrids and 30 BXD
recombinant inbred lines were phenotyped for hydroxyproline levels
and collagen areas after induction of chronic liver injury and ﬁbrosis
using CCl4. CCl4 (0.7 mg/kg body weight, in a 1:1 mixture with-
mineral oil) was administered for 6 wk with two intraperitoneal
injections per week. The mice do not develop ﬁbrosis when fed
a chow diet without the administration of CCl4. We measured he-
patic collagen contents (hydroxyproline levels and collagen areas) as
quantitative parameters and ﬁbrosis stages as semiquantitative meas-
ures in histological liver sections as previously described (Hall et al.
2014). Phenotypic characterization of hepatic collagen was initially
performed in male and female mice. Transcriptomes of CCl4-treated
BXD lines were analyzed in female mice (three arrays per line)
because they showed more pronounced differences in ﬁbrosis pro-
gression among the BXD lines. The mice were chow-fed and the
transcriptome of three female mice from each BXD line after CCl4
challenge was determined with Affymetrix Mouse Gene 1.0 ST
microarrays. These data underwent quality control and normaliza-
tion and were uploaded into the GeneNetwork database (http://
www.genenetwork.org/webqtl/main.py). Using the gene expression
values as quantitative traits, interval mapping was performed to
identify eQTLs as implemented in GeneNetwork.
RESULTS
Hepatic Xbp1s and Socs3 gene expression in A/J and
C57BL/6J mice fed a HFHC diet
Parental mouse strains C57BL/6J and A/J fed a HFHC diet for 8 wk
elicited signiﬁcant differences in the hepatic gene expression of Xbp1s:
1.0 6 0.2 vs. 0.4 6 0.2 in A/J and C57BL/6J mice, respectively (P ,
0.05). There was also a similar difference in hepatic Socs3 gene ex-
pression: 1.0 6 0.2 vs. 0.6 6 0.2 in A/J and C57BL/6J mice, respec-
tively (P , 0.05). Hepatic Xbp1s and Socs3 gene expression in F1
(A/J · C57BL/6J) mice was 0.7 6 0.1 for Xbp1s and 0.7 6 0.2 for
Socs3 (P , 0.05), both signiﬁcantly different from A/J mice. Hepatic
Xbp1s expression also differed between the F1 (A/J · C57BL/6J) and
C57BL/6J mice (Figure 1; n = 8 for all groups). Supporting Informa-
tion, Table S1 shows the Pearson correlation matrix of the phenotypes
Xbp1s and Socs3 in C57BL/6J and A/J mice (as well as for several
phenotypes of the metabolic syndrome).
Figure 1 Hepatic mRNA expression of Xbp1s and
Socs3 in A/J, C57BL/6, and F1(A/J · C57BL/6J)
mice. Mice were fed a 60% high-fat, high-caloric
(HFHC) diet for 8 wk and hepatic mRNA expression
of (A) Xbp1s and (B) Socs3 measured using RT-PCR.
RLU, random light units. Mean 6 SEM. A/J (white),
C57BL/6J (black), F1(A/J · C57BL/6J) (gray) mice;
ap , 0.05 vs. C57BL/6J; bp , 0.05 vs. A/J mice;
cp , 0.05 vs. C57BL/6J mice (n = 8 for all groups).
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Identiﬁcation of eQTLs for hepatic Xbp1s and Socs3
gene expression using F2 (A/J × C57BL/6J) mice fed
a HFHC diet
Xbp1 and Socs3 are both located on mouse chromosome 11 (Xbp1: 5.5
Mb and Socs3: 118.0 Mb). We identiﬁed an overlapping eQTL for
Xbp1s and Socs3 on chromosome 1 (181.5 Mb), with LOD scores of
4.79 and 6.18, respectively. Additional overlapping eQTLs were also
identiﬁed on chromosome 11 (56.2 and 58.4 Mb). There was also an
eQTL identiﬁed for Socs3 on chromosome 12 (113.4 Mb) with a LOD
score of 3.53 (Table 1). Figure 2 and Figure 3 show the whole genome
LOD plots and the eQTL linkage maps, respectively. Microarray anal-
ysis identiﬁed eight and nine differentially expressed candidate genes
within the overlapping eQTLs on chromosomes 1 and 11, respectively;
ﬁve differentially expressed genes were identiﬁed in the Socs3 eQTL on
chromosome 12 (Table 2).
Consomic mice replacing A/J Chr 11, but not Chr 1, into
C57BL/6J mice reverses the Xbp1s and
Socs3 phenotypes
Because eQTLs for both Xbp1s and Socs3 were identiﬁed on chro-
mosomes 1 and 11, we performed RT-PCR of Xbp1s and Socs3 on
hepatic mRNA isolated from C57BL/6J-Chr 1A/J/ NaJ and C57BL/
6J-Chr 11A/J/ NaJ CSS mice, and a new cohort of A/J and C57BL/6J
mice, fed the HFHC diet for 8 wk. Hepatic gene expression of
Xbp1s was 1.0 6 0.2 and 0.6 6 0.2 in A/J and C57BL/6J-Chr
11A/J/ NaJ mice, and 0.3 6 0.2 and 0.2 6 0.2 in C57BL/6J and
C57BL/6J-Chr 1A/J/ NaJ mice (Figure 4). Therefore, Xbp1s gene
expression was higher in C57BL/6J-Chr 11A/J/ NaJ mice than in
C57BL6/J mice (P , 0.05), but was similar in C57BL/6J-Chr 1A/J/
NaJ mice and C57BL/6 mice. Replacement of A/J chromosome 11,
but not chromosome 1, into strain C57BL/6 mice reversed the
Xbp1s phenotype. Hepatic Socs3 gene expression was similar (1.0 6
0.2 and 1.0 6 0.2 RLU) in A/J and C57BL/6J-Chr 11A/J/ NaJ mice,
but was also lower in both the C57BL/6J and C57BL/6J-Chr 1A/J/
NaJ mice, at 0.5 6 0.2 and 0.5 6 0.2 RLU, respectively (P , 0.05;
n = 8). Transfer of A/J chromosome 11, but not chromosome 1, into
C57BL/6J mice reversed the Socs3 phenotype, similar to the ﬁndings
of hepatic Xbp1s mRNA expression.
Identiﬁcation of QTL for the metabolic syndrome using
F2 (A/J × C57BL/6J) mice fed a HFHC diet
Table S2 reveals signiﬁcant differences that were noted between
C57BL/6J mice and A/J mice with respect to several metabolic syn-
drome phenotypes: body weight gain, hepatic triglycerides, fasting
serum insulin, fasting serum glucose, and QUICKI, Therefore, we
performed QTL analysis with respect to these phenotypes. QTL anal-
ysis identiﬁed several chromosomal loci associated with body weight
gain, fasting serum insulin, and fasting serum glucose; however, no
QTL were identiﬁed for the phenotypes of hepatic triglycerides or
QUICKI (Table S3).
Identiﬁcation of eQTLs for hepatic Xbp1 and Socs3
gene expression in the CCl4 model
To further conﬁrm that the regulation of hepatic Xbp1s and Socs3
expression is altered in a second animal model of liver injury, we used
the carbon tetrachloride (CCl4) model of chronic liver injury and
ﬁbrogenesis. Wild-type mice fed chow without CCl4 do not develop
spontaneous hepatic ﬁbrosis. For this analysis, we searched for co-
inciding regulatory loci within the Socs3 and Xbp1 eQTLs on mouse
chromosome 1 (164.4–190.5 Mb), chromosome 11 (41.1–73.1 Mb),
and chromosome 12 (109.9–117.4 Mb) in the BXD reference popu-
lation to allow systematic mapping and integration of multiple com-
plex traits (Andreux et al. 2012). We initially mapped hepatic
expression values of Socs3 and Xbp1s using our microarray-based
expression dataset. Figure 5 shows the interval mapping/regression
analysis for the phenotype of hepatic Socs3 expression. The most
signiﬁcant loci were identiﬁed on chromosome 1 at 185.2–186.6 Mb
for Xbp1 (LOD 3.5; PG = 0.08) and 193.3–197.1 Mb for Socs3 (LOD
4.4, PG = 0.01), chromosome 4 at 62.4–68.9 Mb for Xbp1 (LOD 3.1,
PG= 0.02), and chromosome 12 at 83.9–89.9 Mb for Socs3 (LOD 5.6;
PG = 0.002). Of note, the eQTLs for Socs3 and Xbp1 on chromosomes
1 that determine hepatic expression levels after CCl4 challenge co-
incide with loci that determine gene expression on the HFHC diet
as well as eQTLs in control BXD. These ﬁndings suggest that baseline
expression differences due to genetic variation confer susceptibility to
liver injury. Furthermore, the expression differences are inversely cor-
related with Sirius red-stained collagen areas in livers from CCl4-
treated animals (P , 0.001) (Hall et al. 2014). We also identiﬁed
several genes potentially regulated from within the Socs3 and Xbp1
eQTLs. Table 3 summarizes these cis-regulated differentially expressed
genes identiﬁed using the BXD lines that co-localize with the eQTLs
identiﬁed in the HFHC model. Among the regulated genes, only Darc
and Zfp39 inherit nsSNPs in coding regions differentiating between
C57BL/6J and A/J or DBA/2J mice, respectively.
DISCUSSION
With the prevalence of NALFD rapidly increasing, it is essential that
we gain a better understanding of the pathogenesis and progression of
fatty liver disease. Although NAFLD has a hereditary component, the
genetics of NAFLD are poorly understood (Schwimmer et al. 2009;
Wilfred de Alwis and Day 2008). HFHC diets have been extensively
utilized for murine models of obesity, diabetes, and fatty liver. Mice
fed this diet develop obesity and many of the components of the
metabolic syndrome in a strain-speciﬁc manner (Minkina et al. 2012;
Jiang et al. 2005; Becker et al. 2004; Schmid et al. 2004; Kobayashi
et al. 2004; Rangnekar et al. 2006). In this study, A/J and C57BL/6J
n Table 1 Mouse chromosome eQTL locations for Xbp1s and Socs using F2 (A/J · C57BL/6J) mice
CHR Trait LOD SNP Position (Mb) Interval (Mb) # Genes Diff. SNPs a a/SD d d/SD d/a
1 Xbp1s 4.79 rs 13476265 181.5 162.0–183.6 265 24,755 0.123 0.375 20.051 20.155 20.413
1 Socs3 6.18 rs 13476265 181.5 172.5–188.7 151 14,519 0.129 0.407 20.077 20.244 20.600
11 Xbp1s 3.11 rs 3684076 56.2 41.3–73.3 503 14,835 20.101 20.307 20.054 20.165 0.537
11 Socs3 3.09 rs 3697686 58.4 44.2–68.8 337 11,613 20.100 20.315 20.046 60.463 0.463
12 Socs3 3.53 rs 13481655 113.4 108.7–116.2 79 6446 0.046 0.145 20.131 20.415 22.865
Positive “a” values indicate that at a locus, the homozygous C57BL/6Jt trait mean is greater than the mean of the A/J homozygotes. Negative “d” values indicate that
at that locus, the heterozygote trait mean is closer to the A/J homozygote mean than the C57BL/6J homozygote mean. CHR, chromosome; SNP, SNP marker closest
to peak LOD score; Interval = 1.0–LOD support interval surrounding the peak LOD score; # genes = number of protein coding genes within the support interval; Diff.
SNPs = number of differential SNPS predicted by MGI in the interval; SD = value in SD units for the trait. Intervals and positions are in megabases (Mb).
490 | S. Pasricha et al.
mice were fed a HFHC diet for 8 wk to identify eQTLs and candidate
genes that contribute to NAFLD.
Xbp1s is a key regulator in the IRE1a signaling pathway of the
unfolded protein response (UPR), which is activated by ER stress.
Hepatic ER stress occurs due to insulin resistance, diabetes, obesity,
and several liver diseases, including fatty liver, hepatitis C, and alpha-1
antitrypsin deﬁciency (Ji 2008; Lawless et al. 2004; Li et al. 2009; Puri
et al. 2008; Malhi and Kaufman 2011). In addition to its role in the
UPR, hepatic Xbp1s is an important regulator of fatty acid synthesis
and systemic lipid metabolism (Lee et al. 2008; Sha et al. 2009; Ye
et al. 2012). Dysregulation of hepatic Xbp1s expression has been
shown to be important in the pathogenesis of human NASH (Puri
et al. 2008). In addition, several studies have also demonstrated the
important role of Socs3 in the pathogenesis of nonalcoholic steatohep-
atitis, regulating insulin sensitivity, leptin signaling, glucose metabo-
lism, lipogenesis, and fatty liver (Wang et al. 2009; Ihle 1995; Muraoka
et al. 2003; Kievit et al. 2006; Howard et al. 2004; Dittrich et al. 2012;
Sachithanandan et al. 2010).
When fed a HFHC diet, hepatic gene expression of both Xbp1s and
Socs3 was greater in A/J mice compared with C57BL6/J mice. In
contrast, there were no differences in hepatic gene expression of either
Xbp1s or Socs3 in chow-fed mice, indicating that the phenotypic
change is elicited by feeding the HFHC diet for 8 wk. The increased
expression of both genes is likely a cellular response to prevent further
liver injury, with activation of the unfolded protein response (UPR)
and suppression of inﬂammatory cytokines.
After determining that both hepatic Xbp1s and Socs3 mRNA ex-
pression was differentially expressed in HFHC diet-fed A/J and
C57BL/6 mice, we applied eQTL analysis to identify genetic loci that
may be important in the regulation of these genes that inﬂuence the
pathogenesis of fatty liver disease. We identiﬁed overlapping eQTLs
on mouse chromosomes 1 and 11 that were associated with both
hepatic Xbp1s and Socs3 expression. We also identiﬁed an addi-
tional eQTL for Socs3 on chromosome 12. Of note, the murine
genes for Xbp1 and Socs3 are located on chromosome 11, although
both genes are over 50 Mb away from SNPs rs3684076 and
rs3697686 marking the eQTLs. Assuming that a window of 65 Mb
is used to deﬁne a cis-QTL, this suggests that they are trans eQTLs
(http://www.genenetwork.org/gghelp.html). Using microarray analy-
sis, we identiﬁed differentially expressed candidate genes in the over-
lapping eQTL regions on chromosomes 1 and 11; as well as ﬁve
additional differentially expressed candidate genes in the Socs3 eQTL
on chromosome 12. No genes that are known to be important in the
pathogenesis of nonalcoholic steatohepatitis were identiﬁed to be dif-
ferentially expressed in these loci or the syntenic human loci.
Chromosome substitution strains (CSS) of mice are widely used
for gene discovery, genetic and epigenetic studies, functional charac-
terizations, and systems analysis (Singer et al. 2004; Hines et al. 2011).
When C57BL/6J-Chr 11A/J/ NaJ mice were fed a HFHC diet for 8
wk, both hepatic Xbp1s and Socs3 gene expression was similar to A/J
mice, yet differed from C57BL/6J mice. In contrast, hepatic Xbp1s or
Socs3 gene expression in C57BL/6J-Chr 1A/J/ NaJ mice remained sim-
ilar to C57BL/6J mice. This demonstrates that the replacement of the
C57BL6/J chromosome 11 with A/J chromosome 11 reverses the gene
expression phenotype of both Xbp1s and Socs3 expression from
a C57BL/6J to an A/J phenotype, supporting the physiologic relevance
of the eQTL. Although C57BL/6J-Chr 1A/J/NaJ and C57BL/6J mice
had similar hepatic gene expression of Xbp1s and Socs3, it does not
exclude the physiologic relevance of the eQTL on chromosome 1
because replacement of the entire chromosome may also change other
nonidentiﬁed QTL on the chromosome.
We also identiﬁed QTL for the phenotypes of serum insulin levels,
serum glucose, and weight gain. A QTL on Chr 1 for the phenotype
of serum insulin has a small overlapping region with the eQTLs for
Xbp1s and Socs3 on Chr 1. We did not identify any QTLs for the
phenotypes of hepatic triglycerides or QUICKI. QTLs for murine
hepatic triglyceride have been previously reported (Minkina et al.
2012; Lemoine and Serfaty 2012).
C57BL/6J and A/J mice have been commonly used for models of
obesity, diabetes, fatty liver, and the metabolic syndrome (Alevizos
et al. 2007; Hall et al. 2010; Li et al. 2005; Nishina et al. 1993). Several
studies have determined that C57BL/6J are sensitive to and that A/J
mice are resistant to metabolic syndrome phenotypes, and our ﬁnd-
ings are similar to published data. However, human nonalcoholic
steatohepatitis (fatty liver with inﬂammation and ﬁbrosis) is associated
with inappropriately low levels of hepatic XBP1 expression compared
with bland hepatic steatosis (fatty liver without inﬂammation and
ﬁbrosis) (Puri et al. 2008). Consistent with these data, we have de-
termined that when liver-speciﬁc Xbp1-knockout mice in a C57BL/6J
background are fed a high-fat/sucrose-fructose diet, they are more
susceptible to develop progressive, ﬁbrosing steatohepatitis with less
steatosis than ﬂox control mice. Therefore, the hepatic phenotype of
the liver-speciﬁc Xbp1-null mice is similar to that of C57BL/6J mice,
whereas ﬂox controls have a phenotype similar as A/J mice. Socs3 has
also been demonstrated in several studies to be an important mediator
of both murine and human NASH (Prpic et al. 2003; Bergen et al.
1999; Parekh et al. 1998; Surwit et al. 1997; Winzell and Ahren 2004;
Livingston et al. 1994; Surwit et al. 1988; Tilg 2010; Sachithanandan
et al. 2010; Surwit et al. 1995; Watson et al. 2000). Previous studies
have also identiﬁed other QTL for the metabolic syndrome in mice
(Jiang et al. 2005; Rangnekar et al. 2006). In this study, we identiﬁed
Figure 2 Whole genome LOD plots of eQTLs identiﬁed in A/J and
C57BL/6J mice fed a high-fat diet.
Figure 3 eQTL linkage maps of A/J and
C57BL/6J mice fed a high-fat diet. Xbp1s
(dashed line). Socs3 (solid line).
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14 QTL that are related to metabolic syndrome phenotypes, but we
did not identify QTL for hepatic triglycerides.
To determine whether the identiﬁed regulatory eQTLs for Xbp1s
and Socs3may be important in other forms of liver injury, we used the
CCl4 model of hepatotoxicity and ﬁbrosis using the BXD lines as an
established murine reference panel for systems genetics (Andreux
et al. 2012). eQTL analysis was performed in F2 (A/J · C57BL/6J)
mice because feeding a HFHC diet to A/J and C57BL/6J mice is a well-
established model for genetic and physiologic studies of the metabolic
syndrome. The BXD lines, however, provided an efﬁcient murine
model for the experiments administering CCl4. In this second model
of liver injury, we identiﬁed signiﬁcant regulatory loci for Socs3 and
Xbp1s expression on chromosomes 1 and 12, including an overlapping
region on chromosome 1 that is inﬂuenced by the parental C57BL/6J
allele in both experimental crosses.
A GWAS study of the Dallas Heart study population has revealed
that a polymorphism of PNPLA3 (rs738409; I148M) is strongly asso-
ciated with increased hepatic fat levels and susceptibility to nonalco-
holic fatty liver disease (Romeo et al. 2008). This polymorphism has
subsequently been associated with the severity of NASH, liver stiffness,
ﬁbrosis, and potentially hepatocellular carcinoma. Overexpression of the
PNPLA3 I148M polymorphism in mice also causes hepatic steatosis
and PNPLA3 has been shown to regulate hepatic lipid metabo-
lism (Basantani et al. 2011; Chen et al. 2010; Li et al. 2012; Ruhanen
et al. 2014; Singal et al. 2014; Said 2013; Pingitore et al. 2014; Krawczyk
et al. 2013; Peng et al. 2012; Santoro et al. 2010; Rotman et al.
n Table 2 Differentially expressed genes from C57BL/6J and A/J mice located within the Xbp1s and Socs3 eQTLs
Gene Name Entrez ID
Average
Expression P SNP nsSNP
Chr 1 Apcs Serum amyloid P-component 20219 13.12 4.58E-23 4 0
Darc Duffy blood group, chemokine receptor 13349 8.73 1.88E-13 0 0
Dusp23 Dual speciﬁcity phosphatase 23 68440 10.02 4.40E-12 38 0
Ephx Epoxide hydrolase 1, microsomal 13849 13.18 1.07E-04 52 0
F11 r F11 receptor 16456 9.52 1.03E-18 112 0
Fcer1g Fc receptor, IgE, high afﬁnity I,polypeptide 14127 8.53 1.35E-30 39 0
Fmo3 Flavin containing monooxygenase 3 14262 11.23 2.04E-08 4 0
Gm5561 Predicted gene 5561 433941 11.19 3.03E-12 0 0
Mgst3 Microsomal glutathione S-transferase 3 66447 11.02 1.60E-03 0 0
Pex19 Peroxisomal biogenesis factor 19 19298 12.31 7.24E-11 65 1
Psen2 Presenilin 2 19165 10.9 9.43E-18 31 0
Rgs4 Regulator of G-protein signaling 4 19736 8.88 1.41E-06 25 0
Srp9 Signal recognition particle 9 27058 9.61 1.29E-14 28 0
Susd4 Sushi domain containing 4 96935 9.05 4.36E-05 10 0
Uap1 UDP-N-acetylglucosamine pyrophosphorylase 1 107652 9.5 1.47E-16 28 0
Chr 11 Atox1 ATX1 (antioxidant protein 1) homolog 1 (yeast) 11927 12.24 2.06E-13 0 0
Dhrs1 Dehydrogenase/reductase (SDR family) member 1 52585 12.1 7.32E-11 0 0
Igtp Interferon gamma induced GTPase 16145 11.05 2.70E-07 23 2
Pemt Phosphatidylethanolamine N-methyltransferase 18618 13.15 1.72E-09 30 0
Snap47 Synaptosomal-associated protein, 47 67826 8.89 1.30E-14 6 0
Timd2 T-cell immunoglobulin and mucin domain containing 2 171284 12.74 1.49E-18 41 0
Timd4 T-cell immunoglobulin and mucin domain containing 4 276891 8.87 2.88E-08 49 2
Trim11 Tripartite motif-containing 11 94091 8.32 8.34E-28 30 0
Zfp39 Zinc ﬁnger protein 39 22698 8.44 9.31 E-16 33 2
Chr 12 Adssl1 Adenylosuccinate synthetase like 1 111565 11.62 6.94E-13 56 0
Amn Amnionless 93835 8.42 1.56E-13 7 1
AW555464 Expressed sequence AW555464 217882 11.28 1.24E-15 43 2
Ckb Creatine kinase, brain 12709 9.81 8.69E-05 7 0
Ppp1r13b Protein phosphatase 1, regulatory subunit 13B 21981 8.89 9.16E-13 98 0
Differentially expressed genes in the eQTLs. The genes on Chr 1 and Chr 11 are in both the Xbp1s and Socs3 eQTL. The genes on Chr 12 are in a Socs3 eQTL. SNP,
differential SNPs between strains; nsSNP, nsSNPs differential SNPs.
Figure 4 Hepatic mRNA expression of Xbp1s and
Socs3 in A/J, C57BL/6J, and C57BL/6J-Chr 1A/J/
NaJ and C57BL/6J-Chr 11A/J/NaJ mice. Male A/J,
C57BL/6J, C57BL/6J-Chr 1A/J/NaJ, and C57BL/6J-
Chr 11A/J/NaJ mice were fed a 60% high-fat, high-
caloric (HFHC) diet for 8 wk and hepatic mRNA
expression of (A) Xbp1s and (B) Socs3 gene expres-
sion measured using RT-PCR. RLU, random light
units. Mean 6 SEM. A/J (white), C57BL/6J (black),
C57BL/6J-Chr 1A/J/NaJ (Chr 1, light gray), and
C57BL/6J-Chr 11A/J/NaJ (Chr 11, dark gray). ap ,
0.05 vs. both C57BL/6J and C57BL/6J-Chr 1A/J/
NaJ mice (n = 8).
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2010; Speliotes et al. 2010; Zain et al. 2012). Therefore, increasing
evidence indicates that PNPLA3 polymorphisms have an important
role in hepatic lipid metabolism and human fatty liver disorders. A
TM6SF2 variant confers susceptibility to human nonalcoholic fatty
liver disease, as well as inﬂuences total cholesterol and myocardial
infarction risk (Kozlitina et al. 2014; Holmen et al. 2014; Glimcher
and Lee 2009). Recent data also demonstrate that UDP-galactose-
4-epimerase (GalE) is a direct transcriptional target of Xbp1s that is
located at 136 Mb on chromosome 4 within our QTL interval for
weight gain. Several SNPs, including rs2645424, rs343062, SNP
rs1227756, rs6591182, rs887304, rs2499604, rs6487679, rs1421201,
and rs2710833, have been associated with NAFLD, NASH, or serum
aminotransferase elevation (Chalasani et al. 2010; Kilpelainen et al.
2011). Signiﬁcant associations with histologic NAFLD have also
been identiﬁed at variants in or near NCAN, GCKR, and LYPLAL1
(Speliotes et al. 2011). The roles of these SNPs in fatty liver diseases
and lipid metabolism require further investigation.
Hepatic Xbp1s is induced by the endoplasmic reticulum stress that
occurs in viral hepatitis, alpha-1 antitrypsin deﬁciency, obesity, insulin
resistance, and hepatic steatosis. Xbp1s is formed by an atypical splice
mechanism in which the endonuclease IRE-12 excises 26 nucleotides
from the unspliced Xbp1 and causes a frame shift that removes an
early stop codon. Socs3 is a negative regulator of cytokine signaling,
with expression induced by cytokines such as interferon-g, interleukin-
6, and interleukin-10. None of the candidate genes that we identiﬁed are
known to regulate Xbp1s or Socs3, nor have they previously been asso-
ciated with the pathogenesis of fatty liver.
Human NAFLD is a highly prevalent disease that is closely
associated with the metabolic syndrome, although the pathogenesis
remains poorly understood. Several studies have shown that genetic
factors are important in the pathogenesis of fatty liver; however, many
of the speciﬁc genetic factors remain unknown. In this study, we have
identiﬁed overlapping eQTLs for the phenotypes of Xbp1s and Socs3
expression levels, genes that are likely important in the pathogenesis of
Figure 5 Interval mapping/regression analysis of BXD mice treated with carbon tetrachloride (CCl4). Chow-fed BXD murine lines were treated
with CCl4 and Socs3 hepatic gene expression was measured. eQTLs were identiﬁed using interval mapping as implemented in GeneNetwork.
n Table 3 Differentially expressed hepatic genes identiﬁed in Xbp1s and Socs3 eQTLs regions that are cis-regulated in BXD mice treated
with CCl4
eQTL (BXD)
Cis-Regulated Genes
(Gene ID)
Gene
Location
(Mb)
Mean
Hepatic
mRNA
Expression
Max.
LOD
Max. LOD
Location
(Chr:Mb)
nsSNP Variants
Chr Trait
Location
(Mb)
Allele
Effecta B D A/J
Mgst3: Microsomal glutathione
S-transferase 3 (66447)
169.3 9.8 6.7 Chr1: 169.2
Pex19: Peroxisomal biogenesis
factor 19 (19298)
174.1 11.2 2.4 Chr1: 125.0
1 Socs3 187.0–187.7 20.122 (B) Dusp23: Dual speciﬁcity
phosphatase 23 (68440)
184.6 9.6 5.7 Chr1: 174.2
Xbp1 186.2–186.6 20.102 (B) Apcs: Serum amyloid
P-component (20219)
174.8 12.0 7.5 Chr1: 173.0
Darc: Duffy blood group,
chemokine receptor (13349)
175.3 8.5 5.4 Chr1: 174.2 A G G
Psen2: Presenilin 2 (19165) 182.2 10.8 4.3 Chr1: 182.2
11 Socs3 106.5–106.8 20.097 (B) Zfp39: Zinc ﬁnger protein 39
(22698)
58.7 8.7 10.6 Chr11: 58.9 A G G
12 Socs3 88.2–89.9 0.114 (D) Amn: Amnionless (93835) 112.5 8.4 7.1 Chr12: 112.4 T C C
a
Allele effects are estimated change in trait mean (gene expression) by replacement of one allele by the other: negative values indicate that higher expression values
are produced by the C57BL/6J (B) allele and positive values by DBA/2J (D) allele.
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fatty liver disorders. We have also used microarray analysis to identify
differentially expressed candidate genes in the eQTL regions. Future
studies using ﬁne-mapping techniques, positional cloning, or geneti-
cally altered mice may identify the genes or polymorphisms that are
responsible for disease expression. Given the increasing prevalence of
NAFLD, it is essential that we further understand the genetics and
pathophysiology of fatty liver diseases so that we can develop rationale
therapeutic options for this common liver disease.
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